|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.21 USD | -2.53% |
|
-2.87% | -9.18% |
| Jun. 04 | Exact Sciences Corporation, Q1 2025 Earnings Call, May 01, 2025 | |
| Jun. 03 | Exact Sciences Corporation Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 08:40 AM |
Company Valuation: Exact Sciences Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 21,070 | 13,412 | 8,797 | 13,379 | 10,399 | 9,911 | - | - |
| Change | - | -36.35% | -34.41% | 52.09% | -22.27% | -4.7% | - | - |
| Enterprise Value (EV) 1 | 20,573 | 14,561 | 10,401 | 14,916 | 11,682 | 11,368 | 11,096 | 10,698 |
| Change | - | -29.22% | -28.57% | 43.41% | -21.68% | -2.69% | -2.39% | -3.59% |
| P/E ratio | -23.6x | -22.4x | -14x | -65.5x | -10.1x | -84.3x | 182x | 47.9x |
| PBR | 7.09x | 3.94x | 2.87x | 4.27x | 4.34x | 3.72x | 3.25x | 2.76x |
| PEG | - | 0.6x | -8.12x | 1x | -0x | 0.9x | -1x | 0x |
| Capitalization / Revenue | 14.1x | 7.59x | 4.22x | 5.35x | 3.77x | 3.2x | 2.84x | 2.53x |
| EV / Revenue | 13.8x | 8.24x | 4.99x | 5.97x | 4.23x | 3.67x | 3.18x | 2.73x |
| EV / EBITDA | 789x | -77.4x | -72.5x | 68.2x | 36.1x | 25.9x | 18.5x | 13.6x |
| EV / EBIT | -150x | -24.3x | -17.9x | -57.6x | -79.8x | -117x | 223x | 58.1x |
| EV / FCF | 285x | -61.2x | -23.7x | 467x | 157x | 41.5x | 24.8x | 17.2x |
| FCF Yield | 0.35% | -1.63% | -4.21% | 0.21% | 0.64% | 2.41% | 4.04% | 5.81% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -5.61 | -3.48 | -3.54 | -1.13 | -5.59 | -0.6234 | 0.2886 | 1.097 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,491 | 1,767 | 2,084 | 2,500 | 2,759 | 3,094 | 3,489 | 3,917 |
| EBITDA 1 | 26.08 | -188.1 | -143.4 | 218.8 | 323.4 | 438.3 | 599.2 | 788.1 |
| EBIT 1 | -137.3 | -599.4 | -580 | -259.1 | -146.4 | -96.9 | 49.72 | 184 |
| Net income 1 | -848.5 | -595.6 | -623.5 | -204.1 | -1,029 | -123.1 | 46.7 | 205.2 |
| Net Debt 1 | -496.9 | 1,150 | 1,604 | 1,537 | 1,283 | 1,457 | 1,185 | 786.5 |
| Reference price 2 | 132.49 | 77.83 | 49.51 | 73.98 | 56.19 | 52.54 | 52.54 | 52.54 |
| Nbr of stocks (in thousands) | 159,030 | 172,319 | 177,684 | 180,850 | 185,076 | 188,638 | - | - |
| Announcement Date | 2/16/21 | 2/22/22 | 2/21/23 | 2/21/24 | 2/19/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -84.28x | 3.67x | 25.94x | -.--% | 9.91B | ||
| 682.57x | - | - | - | 2.55B | ||
| 52.54x | 3.54x | 15.76x | -.--% | 2.09B | ||
| -12.46x | 8.2x | -30.65x | -.--% | 1.6B | ||
| 21.47x | 2.54x | 10.02x | 2.41% | 1.11B | ||
| -54.45x | - | - | - | 1.06B | ||
| -1.64x | 1.63x | -1.32x | -.--% | 618M | ||
| -3.35x | 1.4x | -9.56x | -.--% | 304M | ||
| Average | 75.05x | 3.50x | 1.70x | 0.4% | 2.41B | |
| Weighted average by Cap. | 50.00x | 3.91x | 15.88x | 0.17% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- EXAS Stock
- Valuation Exact Sciences Corporation
Select your edition
All financial news and data tailored to specific country editions
